Prosecution Insights
Prosecution Insights
Tech Center 3700 • Art Units: 3792 3794 3796
This examiner grants 87% of resolved cases
Anh-Khoa N. Dinh has resolved 285 cases in Art Unit 3792, located in Tech Center 3700. The examiner maintains an allowance rate of 87.4% and a median days to allowance of 855. The interview lift of 15.2% shows that interviews are a very effective tool for securing an allowance, even with a high baseline. This profile indicates a very favorable environment for patent applicants.
Practitioners in Tech Center 3700 can expect a high success rate, as the 87.4% allowance rate is quite strong. The 15.2% interview lift is a key strategic advantage, suggesting that direct engagement can further improve the odds of a favorable outcome. The 855-day median to allowance provides a reliable benchmark for the length of the process. With 285 resolved cases, the data suggests that a combination of the 87.4% baseline and the 15.2% lift makes this examiner very accessible. Applicants should consider interviews as a primary way to expedite the 855-day timeline in Art Unit 3792.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18917595 | MECHANICAL CIRCULATORY SUPPORT SYSTEM WITH REPOSITIONING SHEATH | Non-Final OA | Boston Scientific Medical Device Limited |
| 19009319 | NEUROSTIMULATION WITH ENHANCED PASSIVE RECOVERY | Non-Final OA | Boston Scientific Neuromodulation Corporation |
| 18532062 | REMOVABLE SHEATH ASSEMBLY | Non-Final OA | EDWARDS LIFESCIENCES CORPORATION |
| 18495683 | SECURING A GUIDEWIRE DELIVERY CATHETER IN THE CORONARY SINUS USING MATERIAL OR ADVANCEMENT MECHANISMS | Final Rejection | EDWARDS LIFESCIENCES CORPORATION |
| 18407810 | REMOTE CARDIOTOXICITY MONITORING | Non-Final OA | ZOLL Medical Corporation |
| 18772733 | ANALYZING ECAP SIGNALS | Final Rejection | Medtronic, Inc. |
| 18704067 | APPARATUS FOR MEASURING VITAL PARAMETERS | Non-Final OA | FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH |
| 18738457 | Arrays for Delivering Tumor Treating Fields (TTFields) with Selectively Addressable Sub-Elements | Non-Final OA | Novocure GmbH |
| 18398714 | COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING TUMOR TREATING FIELDS AND ANTI-VEGFR-2 ANTIBODIES | Non-Final OA | Novocure GmbH |
| 18342303 | Methods For Treating Diabetes With Alternating Electric Fields | Non-Final OA | NOVOCURE GMBH |
| 19014344 | SELF-EXPANDABLE IMPELLER | Non-Final OA | MAGENTA MEDICAL LTD |
| 19013727 | DRIVE CABLE AND AXIAL SHAFT | Non-Final OA | MAGENTA MEDICAL LTD |
| 18637667 | COUPLING WITHIN BEARING HOUSING | Non-Final OA | MAGENTA MEDICAL LTD |
| 18490419 | APPARATUS WITH SEQUENTIALLY IMPLANTED STIMULATORS | Non-Final OA | Nalu Medical, Inc. |
| 18827046 | PERCUTANEOUS HEART PUMP TRANSITIONABLE BETWEEN SEPARATED AND OPERATIONAL CONFIGURATIONS | Final Rejection | TC1 LLC |
| 18722901 | METHODS AND DEVICES FOR CONTROLLED DELIVERY OF NEURAL STIMULATION | Non-Final OA | Saluda Medical Pty Ltd |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy